Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Leonard Seibold

Concepts (200)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Glaucoma
37
2026
267
8.750
Why?
Intraocular Pressure
48
2026
344
7.300
Why?
Glaucoma, Open-Angle
20
2023
109
6.050
Why?
Trabeculectomy
17
2026
76
5.030
Why?
Phacoemulsification
14
2025
124
4.320
Why?
Glaucoma Drainage Implants
11
2026
47
3.100
Why?
Cataract
10
2023
240
2.560
Why?
Ocular Hypertension
7
2022
72
2.410
Why?
Trabecular Meshwork
8
2026
74
2.300
Why?
Tonometry, Ocular
23
2025
107
2.050
Why?
Visual Acuity
13
2025
499
1.870
Why?
Filtering Surgery
7
2026
23
1.710
Why?
Ciliary Body
3
2025
40
1.430
Why?
Pilocarpine
2
2025
16
1.430
Why?
Laser Coagulation
4
2025
80
1.430
Why?
Stents
5
2026
554
1.280
Why?
Endoscopy
3
2025
316
1.200
Why?
Glaucoma, Angle-Closure
2
2020
23
1.160
Why?
Cataract Extraction
5
2020
120
1.010
Why?
Ophthalmology
4
2023
122
1.010
Why?
Laser Therapy
3
2018
146
0.970
Why?
Ophthalmic Solutions
6
2018
82
0.810
Why?
Antihypertensive Agents
5
2017
519
0.760
Why?
Lens Implantation, Intraocular
3
2018
80
0.750
Why?
Retinal Ganglion Cells
3
2025
124
0.690
Why?
Nerve Fibers
2
2012
105
0.660
Why?
Perception
3
2021
373
0.650
Why?
Legislation, Drug
1
2020
73
0.600
Why?
Postoperative Period
7
2025
355
0.590
Why?
Tomography, Optical Coherence
2
2012
283
0.590
Why?
Specialization
1
2020
137
0.580
Why?
Burnout, Professional
2
2025
493
0.570
Why?
Remote Sensing Technology
1
2019
17
0.570
Why?
Retrospective Studies
23
2025
17438
0.550
Why?
Medical Marijuana
1
2020
120
0.550
Why?
Angiogenesis Inhibitors
5
2020
239
0.530
Why?
Humans
66
2026
146342
0.530
Why?
Aged, 80 and over
14
2025
8391
0.520
Why?
Brimonidine Tartrate
1
2017
10
0.500
Why?
Thiazines
1
2017
13
0.500
Why?
Timolol
1
2017
14
0.500
Why?
Marijuana Smoking
1
2020
249
0.490
Why?
Aged
21
2025
26432
0.490
Why?
Marijuana Use
1
2020
218
0.480
Why?
Preservatives, Pharmaceutical
2
2013
28
0.480
Why?
Treatment Outcome
15
2026
11821
0.470
Why?
Prospective Studies
11
2021
8123
0.470
Why?
Sulfonamides
2
2017
594
0.460
Why?
Endophthalmitis
1
2016
46
0.450
Why?
Corneal Diseases
1
2016
48
0.450
Why?
Vision Disorders
3
2025
179
0.440
Why?
Minimally Invasive Surgical Procedures
4
2024
196
0.430
Why?
Middle Aged
22
2025
36619
0.430
Why?
Circadian Rhythm
2
2023
515
0.420
Why?
Ocular Hypotension
3
2022
10
0.400
Why?
Cloprostenol
1
2013
13
0.400
Why?
Prosthesis Implantation
4
2022
156
0.390
Why?
Physicians
1
2022
955
0.390
Why?
Antibodies, Monoclonal
1
2020
1512
0.380
Why?
Follow-Up Studies
7
2025
5439
0.370
Why?
Benzalkonium Compounds
1
2012
15
0.370
Why?
Visual Fields
2
2025
120
0.360
Why?
Male
28
2025
73396
0.360
Why?
Drug Combinations
3
2020
400
0.360
Why?
Female
29
2025
79499
0.360
Why?
Adipocytes
1
2012
223
0.330
Why?
Blood Pressure
2
2017
1765
0.320
Why?
Wound Healing
2
2012
354
0.320
Why?
Stainless Steel
1
2010
19
0.320
Why?
Optic Disk
1
2010
57
0.310
Why?
Contact Lenses
2
2020
13
0.300
Why?
Uveitis
2
2022
152
0.300
Why?
Antineoplastic Agents
1
2020
2219
0.280
Why?
Prednisolone
2
2020
65
0.270
Why?
Adult
17
2025
41087
0.260
Why?
Software
1
2012
676
0.250
Why?
Reproducibility of Results
4
2024
3416
0.220
Why?
Miotics
1
2025
6
0.220
Why?
Optometry
1
2025
8
0.220
Why?
Muscarinic Agonists
1
2025
14
0.220
Why?
Optometrists
1
2025
12
0.220
Why?
Visual Pathways
1
2025
61
0.220
Why?
Optic Nerve Diseases
1
2025
49
0.210
Why?
Alkylating Agents
2
2016
23
0.210
Why?
Cross-Sectional Studies
5
2022
5899
0.210
Why?
Glaucoma, Neovascular
2
2015
10
0.210
Why?
Postoperative Care
2
2025
301
0.200
Why?
Glucocorticoids
2
2020
536
0.200
Why?
Sleep
2
2023
896
0.200
Why?
Macular Edema
1
2023
49
0.190
Why?
Outpatient Clinics, Hospital
1
2023
80
0.180
Why?
Surveys and Questionnaires
5
2025
6073
0.180
Why?
Communication Barriers
1
2023
129
0.170
Why?
Heart Rate
2
2017
846
0.170
Why?
Manometry
1
2021
96
0.160
Why?
Diabetic Retinopathy
1
2023
211
0.160
Why?
Cyclopentolate
1
2020
3
0.160
Why?
Microscopy, Acoustic
1
2020
10
0.160
Why?
Gonioscopy
1
2020
12
0.160
Why?
Administration, Ophthalmic
1
2020
16
0.160
Why?
Posterior Capsular Rupture, Ocular
1
2020
6
0.160
Why?
Vascular Endothelial Growth Factor A
4
2020
545
0.160
Why?
Muscarinic Antagonists
1
2020
30
0.160
Why?
Amyloidosis
1
2020
43
0.160
Why?
Diagnostic Techniques, Ophthalmological
1
2020
55
0.150
Why?
Language
1
2023
315
0.150
Why?
Patient Reported Outcome Measures
1
2024
516
0.150
Why?
Health Status Disparities
1
2023
322
0.150
Why?
Retinal Diseases
1
2020
102
0.150
Why?
Infusions, Intravenous
1
2020
432
0.150
Why?
Eye Diseases
1
2020
100
0.150
Why?
Intraoperative Complications
1
2020
157
0.140
Why?
Mitomycin
2
2016
31
0.140
Why?
Preoperative Period
1
2019
157
0.140
Why?
Magnetic Resonance Imaging
2
2014
3926
0.140
Why?
United States
5
2025
16136
0.140
Why?
Exfoliation Syndrome
1
2018
10
0.140
Why?
Axial Length, Eye
1
2018
17
0.140
Why?
Corneal Pachymetry
1
2018
16
0.140
Why?
Biosensing Techniques
1
2020
143
0.140
Why?
Pseudophakia
1
2018
21
0.140
Why?
Young Adult
6
2025
14330
0.130
Why?
Refraction, Ocular
1
2018
47
0.130
Why?
Uveitis, Anterior
1
2018
27
0.130
Why?
Time Factors
2
2019
7109
0.130
Why?
Intravitreal Injections
4
2020
73
0.120
Why?
Adrenergic alpha-1 Receptor Antagonists
1
2016
18
0.120
Why?
Equipment Design
1
2018
520
0.120
Why?
Fluoroquinolones
1
2016
44
0.120
Why?
Healthcare Disparities
1
2023
733
0.120
Why?
Coronary Artery Disease
1
2022
751
0.110
Why?
Drug Delivery Systems
1
2019
377
0.110
Why?
Lasers, Semiconductor
1
2015
10
0.110
Why?
Drug Packaging
1
2015
41
0.110
Why?
Receptors, Vascular Endothelial Growth Factor
1
2015
109
0.110
Why?
Device Removal
1
2016
149
0.100
Why?
ACTH-Secreting Pituitary Adenoma
1
2014
12
0.100
Why?
Orbital Neoplasms
1
2014
28
0.100
Why?
Travoprost
1
2013
13
0.100
Why?
Ophthalmologic Surgical Procedures
1
2014
91
0.100
Why?
Patient Preference
1
2016
226
0.100
Why?
Antimetabolites
1
2012
21
0.090
Why?
Recombinant Fusion Proteins
1
2015
663
0.090
Why?
Anterior Chamber
1
2012
26
0.090
Why?
Adenoma
1
2014
210
0.090
Why?
Conjunctiva
1
2012
52
0.090
Why?
Blister
1
2012
38
0.090
Why?
Prostaglandins F
1
2011
15
0.090
Why?
Quality of Life
1
2024
3200
0.090
Why?
Telemedicine
1
2021
966
0.080
Why?
Medication Adherence
1
2015
535
0.080
Why?
Equipment Safety
1
2010
38
0.080
Why?
Electromagnetic Fields
1
2010
37
0.080
Why?
Torque
1
2010
82
0.080
Why?
Dexamethasone
1
2012
368
0.070
Why?
Drug Therapy, Combination
1
2012
1036
0.070
Why?
Cell Survival
1
2012
1105
0.070
Why?
Tissue Donors
1
2012
425
0.070
Why?
Reference Values
1
2010
796
0.070
Why?
Diabetes Mellitus, Type 2
1
2023
2623
0.070
Why?
Cohort Studies
1
2019
6077
0.070
Why?
Immunosuppressive Agents
1
2012
829
0.070
Why?
Adolescent
4
2020
22557
0.060
Why?
Inflammation
1
2018
2919
0.060
Why?
Administration, Topical
2
2016
154
0.060
Why?
Geniculate Bodies
1
2025
22
0.060
Why?
Cell Proliferation
1
2012
2502
0.050
Why?
Anti-Bacterial Agents
1
2016
1942
0.050
Why?
Cells, Cultured
1
2012
4118
0.050
Why?
Sickness Impact Profile
1
2024
67
0.050
Why?
Safety-net Providers
1
2023
133
0.040
Why?
Rabbits
2
2012
651
0.040
Why?
Coronary Angiography
1
2022
325
0.040
Why?
Patient Satisfaction
1
2024
706
0.040
Why?
Attitude
1
2021
253
0.040
Why?
Histological Techniques
1
2018
38
0.030
Why?
Prevalence
1
2025
2861
0.030
Why?
Ambulatory Care
1
2023
628
0.030
Why?
Postoperative Complications
2
2021
3034
0.030
Why?
Risk Assessment
2
2020
3712
0.030
Why?
Reoperation
1
2020
645
0.030
Why?
Pharmaceutical Preparations
1
2019
172
0.030
Why?
Microscopy
1
2018
147
0.030
Why?
Perioperative Care
1
2019
235
0.030
Why?
Fibrosis
1
2018
568
0.030
Why?
Medication Errors
1
2015
86
0.030
Why?
Monitoring, Physiologic
1
2016
279
0.030
Why?
Iris
1
2013
23
0.020
Why?
Pilot Projects
1
2018
1888
0.020
Why?
Goblet Cells
1
2012
22
0.020
Why?
Neoplasm Invasiveness
1
2014
504
0.020
Why?
Disease Progression
1
2020
2867
0.020
Why?
Pandemics
1
2021
1707
0.020
Why?
Neovascularization, Pathologic
1
2013
287
0.020
Why?
Prognosis
1
2020
4351
0.020
Why?
Delayed-Action Preparations
1
2012
192
0.020
Why?
Collagen
1
2012
460
0.020
Why?
Dose-Response Relationship, Drug
1
2011
2022
0.020
Why?
Animals
3
2012
38107
0.010
Why?
Child
1
2020
22693
0.010
Why?
Seibold's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)